Literature DB >> 7964695

Eyelid motor abnormalities in progressive supranuclear palsy.

F Grandas1, A Esteban.   

Abstract

Eyelid motor abnormalities found in progressive supranuclear palsy are reviewed. Electrophysiological correlates of blepharospasm, levator inhibition (blepharokolysis) and supranuclear paralysis of lid closure are presented. Disorders of eyelid motility are not uncommon in progressive supranuclear palsy (PSP). They may be found in about one third of patients with this syndrome (Jackson et al., 1983; Golbe et al., 1989). This is not surprising since ocular and eyelid movements are highly coordinated, mainly in the vertical plane (Gordon, 1951; Kennard and Smith, 1963; Kennard and Glaser, 1964), and a supranuclear ophthalmoplegia with down gaze impairment is a cardinal feature of PSP (Steele et al., 1964). The spectrum of eyelid motor disorders described in PSP includes blinking abnormalities, lid retraction, blepharospasm, levator inhibition and supranuclear palsy of eye closure.

Entities:  

Mesh:

Year:  1994        PMID: 7964695     DOI: 10.1007/978-3-7091-6641-3_3

Source DB:  PubMed          Journal:  J Neural Transm Suppl        ISSN: 0303-6995


  4 in total

1.  The graded levator hinge procedure for the correction of upper eyelid retraction (an American Ophthalmological Society thesis).

Authors:  Daniel P Schaefer
Journal:  Trans Am Ophthalmol Soc       Date:  2007

2.  Iron accumulation in the oculomotor nerve of the progressive supranuclear palsy brain.

Authors:  Hansol Lee; Myung Jun Lee; Eun-Joo Kim; Gi Yeong Huh; Jae-Hyeok Lee; HyungJoon Cho
Journal:  Sci Rep       Date:  2021-02-03       Impact factor: 4.379

3.  Eye tracking identifies biomarkers in α-synucleinopathies versus progressive supranuclear palsy.

Authors:  Annette Janzen; Douglas P Munoz; Mahboubeh Habibi; Wolfgang H Oertel; Brian J White; Donald C Brien; Brian C Coe; Heidi C Riek; Julia Perkins; Rachel Yep; Laurent Itti; Lars Timmermann; Christoph Best; Elisabeth Sittig
Journal:  J Neurol       Date:  2022-04-30       Impact factor: 6.682

Review 4.  Oculo-Visual Dysfunction in Parkinson's Disease.

Authors:  R A Armstrong
Journal:  J Parkinsons Dis       Date:  2015       Impact factor: 5.568

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.